News IQ-AI Limited

Equities

Market Closed - London S.E. Other stock markets 11:35:23 2024-05-28 am EDT			5-day change	1st Jan Change
1.4 ^GBX	0.00%		0.00%	-70.21%

May. 23	Celadon ships to US; Oxford BioDynamics-Goodbody pact	AN
May. 20	IQ-AI subsidiary gets second FDA rare paediatric disease designation	AN

Celadon ships to US; Oxford BioDynamics-Goodbody pact	May. 23	AN
IQ-AI subsidiary gets second FDA rare paediatric disease designation	May. 20	AN
IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate	May. 20	MT
Ingenta trades in line; Triple Point Social NAV up	May. 17	AN
IQ-AI Unit Delivers Software to Insel Gruppe	May. 17	MT
IQ-AI subsidiary gets rare paediatric disease designation FDA	May. 10	AN
IQ-AI's Imaging Biometrics Obtains Rare Pediatric Disease Designation for Lead Drug Candidate	May. 10	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	May. 02	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	Apr. 29	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025	Feb. 26	AQ
IQ-AI's Broker Exercises Option to Buy Shares in Placing	Feb. 26	MT
IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development	Feb. 22	MT
IQ-AI shares sink on discounted placing fundraise	Feb. 22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	Feb. 09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	Feb. 09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	Feb. 02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	Feb. 02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	Jan. 10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	Jan. 10	MT

No results for this search